These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
284 related articles for article (PubMed ID: 17896895)
1. Blood management: a primer for clinicians. Boucher BA; Hannon TJ Pharmacotherapy; 2007 Oct; 27(10):1394-411. PubMed ID: 17896895 [TBL] [Abstract][Full Text] [Related]
2. Clinicians as gatekeepers: what is the best route to optimal blood use? Isbister JP Dev Biol (Basel); 2007; 127():9-14. PubMed ID: 17486878 [TBL] [Abstract][Full Text] [Related]
8. Critical pathway for the management of acute heart failure at the Veterans Affairs San Diego Healthcare System: transforming performance measures into cardiac care. Gardetto NJ; Greaney K; Arai L; Brenner A; Carroll KC; Howerton NM; Lee M; Pada L; Tseng M; Maisel AS Crit Pathw Cardiol; 2008 Sep; 7(3):153-72. PubMed ID: 18791404 [TBL] [Abstract][Full Text] [Related]
9. Practical considerations when developing guidelines for managing critical bleeding. Rebuck JA Pharmacotherapy; 2007 Sep; 27(9 Pt 2):103S-109S. PubMed ID: 17723113 [TBL] [Abstract][Full Text] [Related]
10. The clinician's approach to the management of risk. Isbister JP Transfus Sci; 1994 Mar; 15(1):37-48. PubMed ID: 10147197 [TBL] [Abstract][Full Text] [Related]
12. Strategies to preempt and reduce the use of blood products: an Australian perspective. Hofmann A; Farmer S; Towler SC Curr Opin Anaesthesiol; 2012 Feb; 25(1):66-73. PubMed ID: 22157195 [TBL] [Abstract][Full Text] [Related]
13. [Guidelines of the German Medical Association for Therapy with Blood Components and Plasma Derivatives--an introduction. Evidence-based recommendations for the risk-benefit analysis in hemotherapy]. Heim MU Anasthesiol Intensivmed Notfallmed Schmerzther; 2009 Mar; 44(3):186-97; quiz 199. PubMed ID: 19266420 [TBL] [Abstract][Full Text] [Related]
14. Reengineering transfusion and cellular therapy processes hospitalwide: ensuring the safe utilization of blood products. Brooks JP Transfusion; 2005 Oct; 45(4 Suppl):159S-71S. PubMed ID: 16181401 [TBL] [Abstract][Full Text] [Related]
15. An observational study of health professionals' use of evidence to inform the development of clinical management tools. Hutchinson AM; Johnston L J Clin Nurs; 2008 Aug; 17(16):2203-11. PubMed ID: 18705739 [TBL] [Abstract][Full Text] [Related]
16. Role of quality improvement in prevention of inappropriate transfusions. Mohandas A; Foley KA; Nash DB; Doria C Qual Manag Health Care; 2011; 20(4):298-310. PubMed ID: 21971027 [TBL] [Abstract][Full Text] [Related]
17. Management of transfusion related risks: is risk communication to non-experts at all possible? Hossenlopp C Dev Biol (Basel); 2007; 127():249-58. PubMed ID: 17486898 [TBL] [Abstract][Full Text] [Related]
18. Warm fresh whole blood transfusion for severe hemorrhage: U.S. military and potential civilian applications. Spinella PC Crit Care Med; 2008 Jul; 36(7 Suppl):S340-5. PubMed ID: 18594261 [TBL] [Abstract][Full Text] [Related]
19. The science of implementation: changing the practice of critical care. Weinert CR; Mann HJ Curr Opin Crit Care; 2008 Aug; 14(4):460-5. PubMed ID: 18614913 [TBL] [Abstract][Full Text] [Related]
20. Evidence-based medicine, systematic reviews, and guidelines in interventional pain management, part I: introduction and general considerations. Manchikanti L Pain Physician; 2008; 11(2):161-86. PubMed ID: 18354710 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]